Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860230 · ClinicalTrials.gov registry record
Philips FAST Evaluation
A clinical trial of Oxygen Saturation Measurement, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT06860230: Completed study of Oxygen Saturation Measurement, sponsored by Medtronic - MITG.
NCT06860230 is a study of Oxygen Saturation Measurement that has completed, run by Medtronic - MITG. The registered enrollment target is 27 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06860230, a study of Oxygen Saturation Measurement, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of Philips FAST technology with Nellcor sensors
Primary Outcome
Performance will be determined by calculating the accuracy in terms of root mean square difference (ARMS) comparing the noninvasive oxygen saturation measurement (SpO2) to the arterial oxygen saturation (SaO2) value obtained from a reference blood sample.
Conditions Studied
Interventions
- DEVICE Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors
Study Locations (1)
Colorado
- Medtronic Clinical Physiology Lab - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2025-07-11 |
What the finished NCT06860230 record still lists
NCT06860230 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 1 condition, with Oxygen Saturation Measurement appearing as the primary indexed condition, and to 1 intervention - of which Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors is the first listed.
NCT06860230 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06860230 about?
NCT06860230 is a clinical study titled "Philips FAST Evaluation". Evaluation of Philips FAST technology with Nellcor sensors
What is the current status of trial NCT06860230?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2025-03-11. Estimated completion is 2025-07-11.
What conditions does trial NCT06860230 study?
This clinical trial studies the following conditions: Oxygen Saturation Measurement.
What interventions are being tested in trial NCT06860230?
The interventions under investigation include: Philips FAST SpO2 with Nellcor Pulse Oximetry Sensors (DEVICE).
Who is sponsoring clinical trial NCT06860230?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860230 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oxygen Saturation Measurement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI